BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 11486560)

  • 1. Cyclosporine-A induced neurotoxicity after renal transplantation.
    Derici U; Arinsoy T; Sindel S; Tali T; Leventoglu A; Sert S
    Acta Neurol Belg; 2001 Jun; 101(2):124-7. PubMed ID: 11486560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neurotoxicity of cyclosporine].
    Kozłowska I; Rózańiski J; Ciechanowski K
    Wiad Lek; 2006; 59(7-8):516-20. PubMed ID: 17209351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine-induced white and grey matter central nervous system lesions in a pediatric renal transplant patient.
    Jeruss J; Braun SV; Reese JC; Guillot A
    Pediatr Transplant; 1998 Feb; 2(1):45-50. PubMed ID: 10084760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine nephrotoxicity: associated allograft dysfunction at low trough concentration.
    Jankauskiene A; Druskis V; Laurinavicius A
    Clin Nephrol; 2001 Dec; 56(6):S27-9. PubMed ID: 11770808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurotoxicity caused by cyclosporin A in renal transplantation in children].
    Rodríguez E; Delucchi A; Cano F
    Rev Med Chil; 1992 Mar; 120(3):300-3. PubMed ID: 1342484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine neurotoxicity.
    Hauben M
    Pharmacotherapy; 1996; 16(4):576-83. PubMed ID: 8840363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myelodysplastic syndrome with cyclosporine A-induced encephalopathy presenting with a mass effect on the right basal ganglia after cord blood transplantation].
    Koh H; Yamane T; Nakane T; Takeoka Y; Sakamoto E; Kanashima H; Nakamae M; Nakamae H; Koh KR; Mochizuki K; Hayashi N; Hino M
    Rinsho Ketsueki; 2006 Dec; 47(12):1539-43. PubMed ID: 17233473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of calcium-channel antagonists in solid organ transplantation.
    Huntress JD; Papadakos PJ
    New Horiz; 1996 Feb; 4(1):129-33. PubMed ID: 8689268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible everolimus-induced, severe, reversible encephalopathy after cardiac transplantation.
    Tsagalou EP; Anastasiou-Nana MI; Margari ZJ; Vassilopoulos D
    J Heart Lung Transplant; 2007 Jun; 26(6):661-4. PubMed ID: 17543796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible brachial diplegia in a case treated with cyclosporine.
    Morelli N; Mancuso M; Cafforio G; Gori S; Murri L
    Neurology; 2007 Jul; 69(2):220. PubMed ID: 17620558
    [No Abstract]   [Full Text] [Related]  

  • 11. Relation of magnesium level to cyclosporine and metabolic complications in renal transplant recipients.
    Ahmadi F; Naseri R; Lessan-Pezeshki M
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):766-9. PubMed ID: 19736470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine-associated facial paralysis in a child with renal transplant.
    Ozkaya O; Kalman S; Bakkaloğlu S; Buyan N; Söylemezoğlu O
    Pediatr Nephrol; 2002 Jul; 17(7):544-6. PubMed ID: 12172772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical findings and magnetic resonance imaging in severe cyclosporine-related neurotoxicity after allogeneic bone marrow transplantation.
    Trullemans F; Grignard F; Van Camp B; Schots R
    Eur J Haematol; 2001 Aug; 67(2):94-9. PubMed ID: 11722596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical mechanisms of cyclosporine neurotoxicity.
    Serkova NJ; Christians U; Benet LZ
    Mol Interv; 2004 Apr; 4(2):97-107. PubMed ID: 15087483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical neurologic illness in the immunocompromised patient.
    Cohen JA; Raps EC
    Neurol Clin; 1995 Aug; 13(3):659-77. PubMed ID: 7476823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A patient recently transplanted with a living donor kidney develops severe neurological symptoms.
    Heiss S; Krampla W; Klauser-Braun R
    Nephrol Dial Transplant; 2006 Jul; 21(7):2017-9. PubMed ID: 16702199
    [No Abstract]   [Full Text] [Related]  

  • 17. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
    Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
    Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion from tacrolimus to cyclosporine--a based immunosuppression following liver transplantation.
    Doria C; Jain AK; Scott VL; Gruttadauria S; Marino IR; Doyle HR; Fung JJ
    Exp Clin Transplant; 2003 Jun; 1(1):48-55. PubMed ID: 15859907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression of cyclosporia-induced gingival overgrowth upon interruption of drug therapy.
    Mathur H; Moretti AJ; Flaitz CM
    Gen Dent; 2003; 51(2):159-62. PubMed ID: 15055689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological complications in kidney transplant recipients.
    Ponticelli C; Campise MR
    J Nephrol; 2005; 18(5):521-8. PubMed ID: 16299677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.